|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:MedeAnalytics
gptkb:Gavis_Pharmaceuticals
|
|
gptkbp:advertising
|
gptkb:Mr._Deepak_Kumar
gptkb:Mr._Ashok_Mehta
gptkb:Dr._Neha_Singh
gptkb:Mr._Prakash_Joshi
gptkb:Mr._Kunal_Agarwal
Mr. Kedar Khandekar
Mr._Vikram_Singh
Mr._Vinay_Bhatia
Ms._Neelam_Sethi
Ms._Rina_Dutta
|
|
gptkbp:awards
|
Best Company in the Pharmaceutical Sector 2021
Pharma_Company_of_the_Year_2020
|
|
gptkbp:clinicalTrials
|
gptkb:Dr._Mohan_Rao
|
|
gptkbp:customerService
|
gptkb:Mr._Sanjay_Kumar
|
|
gptkbp:employees
|
over 20,000
|
|
gptkbp:founded
|
1968
|
|
gptkbp:founder
|
gptkb:Desh_Bandhu_Gupta
|
|
gptkbp:headCoach
|
gptkb:Dr._Anjali_Verma
|
|
gptkbp:headquarters
|
gptkb:Mumbai,_India
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lupin Pharmaceuticals
|
|
gptkbp:market
|
gptkb:Asia
gptkb:Latin_America
gptkb:North_America
gptkb:Mr._Rajiv_Mehta
Africa
Europe
|
|
gptkbp:operates_in
|
over 100 countries
|
|
gptkbp:operations
|
gptkb:Mr._Nilesh_Gupta
|
|
gptkbp:partnerships
|
gptkb:AstraZeneca
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Merck_&_Co.
Novartis
|
|
gptkbp:products
|
branded medications
generic medications
active pharmaceutical ingredients (APIs)
|
|
gptkbp:regulatoryCompliance
|
gptkb:Ms._Priya_Sharma
Mr. Rajesh K. Gupta
|
|
gptkbp:research
|
gptkb:Dr._Ramesh_Swaminathan
|
|
gptkbp:researchAndDevelopment
|
focus on infectious diseases
focus on chronic diseases
focus on cardiovascular diseases
focus on diabetes
|
|
gptkbp:revenue
|
$2.1 billion (2021)
|
|
gptkbp:sisterCity
|
gptkb:Mr._Suresh_Babu
|
|
gptkbp:social_responsibility
|
gptkb:Ms._Anjali_Joshi
|
|
gptkbp:stockExchange
|
LUPIN
|
|
gptkbp:subsidiary
|
gptkb:Lupin_Pharmaceuticals_USA
gptkb:Lupin_Inc.
gptkb:Lupin_Australia
|
|
gptkbp:supplyChain
|
gptkb:Mr._Anil_Kumar
gptkb:Mr._Ramesh_Iyer
|
|
gptkbp:tactics
|
gptkb:Mr._Raghavendra_Rao
Mr._Sanjay_Gupta
|
|
gptkbp:website
|
www.lupin.com
|